BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Pyxis Oncology, Inc. (PYXS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Pyxis Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
09:28 am
Sale		 2023-12-31 13G Pyxis Oncology, Inc.
PYXS		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -2,938,851decrease
(Position Closed)		 Filing
2023-02-13
6:13 pm
Purchase		 2022-12-31 13G Pyxis Oncology, Inc.
PYXS		 BIOTECHNOLOGY VALUE FUND L P 2,938,851
8.400%		 1,147,500increase
(+64.06%)		 Filing
2021-12-20
5:23 pm
Purchase		 2021-12-10 13G Pyxis Oncology, Inc.
PYXS		 BIOTECHNOLOGY VALUE FUND L P 1,791,351
5.500%		 1,791,351increase
(New Position)		 Filing